This document clarifies the definition of starting materials for specific groups of biologicals. It presents CHMP's current position on the use of variant processes in early manufacturing stages of these products.
Keywords: Starting materials, sourcing, intermediates, heparins, urine derived products, plasma derived medicinal products, manufacturing process